Influence of balloon size on aortic regurgitation in neonates undergoing balloon aortic valvuloplasty--a retrospective study over an 11-year period

J Interv Cardiol. 2013 Apr;26(2):200-7. doi: 10.1111/j.1540-8183.2013.12018.x. Epub 2013 Feb 13.

Abstract

Background: Transcatheter balloon aortic valvuloplasty has become the first-line treatment for critical or severe aortic stenosis in neonates in many centers. Aortic regurgitation following balloon aortic valvuloplasty remains a major concern. An optimal balloon size to aortic annulus ratio in order to minimize aortic regurgitation postprocedure, while relieving the obstruction, has not yet been identified.

Methods and results: In this retrospective study, data from 29 neonates with critical or severe congenital aortic valve stenosis, who underwent balloon aortic valvuloplasty in the first 28 days of life, over an 11-year period, was evaluated. The balloon size used, ranged from 71% to 160% of the annulus size, with an average of 89%, based on the aortic annulus size as measured on angiography. The aortic regurgitation immediately following the procedure was trivial in 8 (27.6%), mild in 13 (44.8%), moderate in 7 (24.1%), and severe in 1 (3.4%) patient. The balloon to annulus ratio had no statistically significant effect on the degree of aortic regurgitation immediately after the procedure (P-value of 0.25), at first follow-up within 6 weeks of the procedure (P-value of 0.76) or at follow-up at 1 year (P-value of 0.52).

Conclusion: This study did not show any significant relationship between the balloon to annulus ratio during interventional dilatation and the degree of aortic regurgitation following the procedure.

MeSH terms

  • Aortic Valve / surgery*
  • Aortic Valve Insufficiency / etiology
  • Aortic Valve Insufficiency / surgery*
  • Aortic Valve Stenosis / congenital*
  • Aortic Valve Stenosis / mortality
  • Aortic Valve Stenosis / surgery
  • Balloon Valvuloplasty / adverse effects
  • Balloon Valvuloplasty / methods*
  • Balloon Valvuloplasty / mortality
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Prosthesis Design / adverse effects*
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome
  • United Kingdom